home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.370 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Geron Corporation Reports Business Highlights and Second Quarter 2023 Financial Results

August 03, 2023

From Geron Corporation

Via Business Wire

Geron to Announce Second Quarter 2023 Financial Results on August 3, 2023

July 27, 2023

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 20, 2023

From Geron Corporation

Via Business Wire

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

Geron (GERN) Q1 2023 Earnings Call Transcript ↗

May 11, 2023

GERN earnings call for the period ending March 31, 2023.

Via The Motley Fool

Recap: Geron Q1 Earnings ↗

May 11, 2023

Via Benzinga

Geron Announces U.S. Expanded Access Protocol for Imetelstat in Lower Risk MDS

June 29, 2023

From Geron Corporation

Via Business Wire

Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now ↗

June 29, 2023

With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend.

Via InvestorPlace

Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 22, 2023

From Geron Corporation

Via Business Wire

What's Going On With Geron Stock Today ↗

June 20, 2023

Geron Corporation (NASDAQ: GERN) submitted a marketing application with the FDA seeking approval for imetelstat for the treatment of transfusion-dependent anemia in adult patients with low- to...

Via Benzinga

Geron Announces Submission of New Drug Application to FDA for First-in-Class Telomerase Inhibitor Imetelstat

June 20, 2023

From Geron Corporation

Via Business Wire

A Preview Of Geron's Earnings ↗

May 10, 2023

Via Benzinga

Geron Announces First Patient Dosed in Investigator-Led Phase 2 IMpress Trial Evaluating Imetelstat in Patients with Relapsed/Refractory AML or Higher Risk MDS

June 13, 2023

From Geron Corporation

Via Business Wire

Geron Announces New Data and Analyses from IMerge Phase 3 Presented at EHA Reporting Robust Durability of Transfusion Independence, Evidence of Disease-Modifying Activity and Favorable Fatigue PRO in Imetelstat-Treated Lower Risk MDS Patients

June 12, 2023

From Geron Corporation

Via Business Wire

Geron to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

June 07, 2023

From Geron Corporation

Via Business Wire

Geron to Host Virtual Investor Event on June 14, 2023

June 06, 2023

From Geron Corporation

Via Business Wire

Market Mixes It Up With A Broad Rally ↗

June 05, 2023

Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.

Via Talk Markets

Geron Announces ASCO Presentation Reporting Durable Continuous Transfusion Independence with Imetelstat in IMerge Phase 3 Lower Risk MDS Patients

June 02, 2023

From Geron Corporation

Via Business Wire

Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

May 31, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END

Via FinancialNewsMedia

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 26, 2023

Gainers Onfolio Holdings, Inc. (NASDAQ: ONFO) gained 73% to $2.02 after the company announced it completed development of a generative AI search tool.

Via Benzinga

Booz Allen Hamilton, Workday, Marvell Technology And Other Big Stocks Moving Higher On Friday ↗

May 26, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 300 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Geron Oral Presentation at Upcoming ASCO Annual Meeting to Highlight Meaningful Continuous Transfusion Independence Observed in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

May 25, 2023

From Geron Corporation

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

May 22, 2023

Via Benzinga

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 18, 2023

From Geron Corporation

Via Business Wire

Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

May 11, 2023

From Geron Corporation

Via Business Wire

Geron Corporation Reports First Quarter 2023 Financial Results and Business Highlights

May 11, 2023

From Geron Corporation

Via Business Wire

Geron to Announce First Quarter 2023 Financial Results on May 11, 2023

May 04, 2023

From Geron Corporation

Via Business Wire

Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial

April 26, 2023

From Geron Corporation

Via Business Wire

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 20, 2023

From Geron Corporation

Via Business Wire

Why Shares of Geron Are Up 30% This Week ↗

April 20, 2023

The company's CEO was scheduled to speak at a virtual conference on Thursday.

Via The Motley Fool

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com